Temasek leads $46m funding in US animal nutrition firm Ascus Biosciences

Temasek leads $46m funding in US animal nutrition firm Ascus Biosciences

Photo: Bloomberg

Singapore state investor Temasek has led the $46-million Series B funding in Ascus Biosciences, a US-based deep science animal health and nutrition company that develops various microbial solutions.

In a statement, Ascus said the funding round was also participated by Anterra Capital, Formation 8, and Cavallo Ventures, with support from various angel investors.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter